Cargando…

The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015

Background: Conclusive information regarding the influence of race on survival among neuroblastoma patients is limited. Our objective is to investigate the association between race and cause-specific survival in pediatric patients diagnosed with neuroblastoma in the US between 1973 and 2015. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Farouk, Farouk S., Viqar, Omar A., Sheikh, Zaid, Castro, Grettel, Barengo, Noël C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399799/
https://www.ncbi.nlm.nih.gov/pubmed/32679868
http://dx.doi.org/10.3390/ijerph17145119
_version_ 1783566215152664576
author Farouk, Farouk S.
Viqar, Omar A.
Sheikh, Zaid
Castro, Grettel
Barengo, Noël C.
author_facet Farouk, Farouk S.
Viqar, Omar A.
Sheikh, Zaid
Castro, Grettel
Barengo, Noël C.
author_sort Farouk, Farouk S.
collection PubMed
description Background: Conclusive information regarding the influence of race on survival among neuroblastoma patients is limited. Our objective is to investigate the association between race and cause-specific survival in pediatric patients diagnosed with neuroblastoma in the US between 1973 and 2015. Methods: This was a retrospective cohort study using the Surveillance, Epidemiology, and End Result (SEER) database. Patients aged 17 and younger of black, white, or Asian Pacific Islander (API) race diagnosed with neuroblastoma from 1973–2015 were included (n = 2,119). The outcome variable was time from diagnosis to death. Covariates included age, gender, ethnicity, stage, tumor site, and year of diagnosis. Cox proportional hazard models were used to calculate hazard ratios and 95% confidence intervals. Results: There were no statistically significant differences in the hazard of survival for blacks (HR 0.93; 95% confidence interval (CI) 0.74–1.16) or API (HR 1.02; 95% CI 0.76–1.37) compared with whites. However, patients diagnosed between 2000–2004 (HR 0.46; 95% CI 0.36–0.59) and 2005–2015 (HR 0.33; 95% CI 0.26–0.41) had decreased hazards of death when compared to patients treated during 1973 to 1999. Conclusions: No association between race and survival time was found. However, survival improved among all patients treated during 2000–2004 and 2005–2015 compared with those treated before the year 2000, leading to a narrowing of the racial disparity based on survival.
format Online
Article
Text
id pubmed-7399799
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73997992020-08-17 The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015 Farouk, Farouk S. Viqar, Omar A. Sheikh, Zaid Castro, Grettel Barengo, Noël C. Int J Environ Res Public Health Article Background: Conclusive information regarding the influence of race on survival among neuroblastoma patients is limited. Our objective is to investigate the association between race and cause-specific survival in pediatric patients diagnosed with neuroblastoma in the US between 1973 and 2015. Methods: This was a retrospective cohort study using the Surveillance, Epidemiology, and End Result (SEER) database. Patients aged 17 and younger of black, white, or Asian Pacific Islander (API) race diagnosed with neuroblastoma from 1973–2015 were included (n = 2,119). The outcome variable was time from diagnosis to death. Covariates included age, gender, ethnicity, stage, tumor site, and year of diagnosis. Cox proportional hazard models were used to calculate hazard ratios and 95% confidence intervals. Results: There were no statistically significant differences in the hazard of survival for blacks (HR 0.93; 95% confidence interval (CI) 0.74–1.16) or API (HR 1.02; 95% CI 0.76–1.37) compared with whites. However, patients diagnosed between 2000–2004 (HR 0.46; 95% CI 0.36–0.59) and 2005–2015 (HR 0.33; 95% CI 0.26–0.41) had decreased hazards of death when compared to patients treated during 1973 to 1999. Conclusions: No association between race and survival time was found. However, survival improved among all patients treated during 2000–2004 and 2005–2015 compared with those treated before the year 2000, leading to a narrowing of the racial disparity based on survival. MDPI 2020-07-15 2020-07 /pmc/articles/PMC7399799/ /pubmed/32679868 http://dx.doi.org/10.3390/ijerph17145119 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Farouk, Farouk S.
Viqar, Omar A.
Sheikh, Zaid
Castro, Grettel
Barengo, Noël C.
The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015
title The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015
title_full The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015
title_fullStr The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015
title_full_unstemmed The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015
title_short The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015
title_sort association between race and survival among pediatric patients with neuroblastoma in the us between 1973 and 2015
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399799/
https://www.ncbi.nlm.nih.gov/pubmed/32679868
http://dx.doi.org/10.3390/ijerph17145119
work_keys_str_mv AT faroukfarouks theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015
AT viqaromara theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015
AT sheikhzaid theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015
AT castrogrettel theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015
AT barengonoelc theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015
AT faroukfarouks associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015
AT viqaromara associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015
AT sheikhzaid associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015
AT castrogrettel associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015
AT barengonoelc associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015